Distinguishing benign from malignant prostate disease
Related Experiment Video
Updated: Sep 26, 2026

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
1Chairman, Department of Surgery, Brooke Medical Center, San Antonio, Texas.
Abstract:
As the incidence and prevalence of prostate cancer increase, there is an increasing need for accurate differentiation of benign from malignant disease. For men with an abnormal screening test such as prostate specific antigen or digital rectal examination, questions arise as to the sensitivity, specificity, and predictive value of the tests. If a test is abnormal, which confirmatory test is most valuable? This article will explore these issues.
More Related Videos
07:34Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
Published on: November 17, 2023
08:40Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
Published on: April 8, 2016